Higginson et al identified factors predicting the need for palliative thoracic radiation therapy following first-line chemotherapy in a patient with a non-small cell lung cancer (NSCLC). These patients may require more aggressive management. The authors are from the University of North Carolina in Chapel Hill.
Patient selection: Stage IIIB or IV NSCLC following first-line chemotherapy
Development of lobar collapse secondary to bronchial obstruction is an indication for palliative thoracic radiation therapy.
Parameters associated with a need for palliative radiation therapy from the multivariate analysis:
(1) diameter of hilar disease in cm
(2) obstructive pneumonia at presentation (prior to chemotherapy)
Parameter |
Finding |
Points |
diameter of hilar disease |
<= 3 cm |
0 |
|
> 3 cm |
1 |
obstructive pneumonia |
absent |
0 |
|
present |
1 |
number of risk factors =
= SUM(points for the 2 parameters)
Interpretation:
• minimum number of risk factors: 0
• maximum number of risk factors: 2
• The need for palliatrive radiation therapy increased with the number of risk factors.
• A patient with no hilar disease is least likely to require an intervention for a pulmonary event.
Number of Risk Factors |
Risk for Palliative RT |
Median Overall Survival |
0 |
low to moderate |
11.3 months |
1 |
moderate |
7.4 months |
2 |
high |
5 months |
Additional risk factors from the univariate analysis:
(1) bronchial or vascular obstruction
(2) cough or chest pain
Specialty: Hematology Oncology, Surgery, general, Pulmonology
ICD-10: ,